IRIS
CENDERELLO, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.567
Totale 1.567
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 1.567
Totale 1.567
Salva come PNG Salva come JPEG
Città #
Genova 1.004
Rapallo 290
Genoa 250
Vado Ligure 16
Bordighera 7
Totale 1.567
Salva come PNG Salva come JPEG
Nome #
Effectiveness, safety, durability and immune recovery in a retrospective, multicentre, observational cohort of ART-experienced, HIV-1-infected patients receiving maraviroc 167
Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: A multicenter regional simulation 147
Bloodstream infections in patients living with HIV in the modern cART era 131
La vaccinazione nel paziente con infezione da HIV: attuali raccomandazioni e strategie multidisciplinari per il raggiungimento dei soggetti suscettibili. L’esperienza della Liguria 120
Chemotherapy Mass Campaigns and Migratory Flows: An Unexpected Connection 111
Cost per care of the first year of direct antiviral agents in the liguria region: A multicenter analysis 109
Reducing CD4+ lymphocyte cell monitoring in HIV-1 stable patients: a forecast of the cost saving 103
Factors associated with hospital admission for COVID-19 in HIV patients 85
HCV elimination plan leads to significant benefits in managing liver-related diseases and hospital interventions: a regional simulation 68
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 66
Bloodstream infections in patients living with HIV infection in the recent cART era: did something change?”. 61
Ligurian Vaccination in HIV Program (LIV in HIV): the experience of Genoa metropolitan area 60
Response to letter to the editor: switch to dolutegravir and unboosted atazanavir 50
The impact of liver disease: a leading cause of hospital admissions in people living vith HIV 49
A Web Based Tool to Enhance Monitoring and Retention in Care for Tuberculosis Affected Patients 46
Early administration of bamlanivimab in combination with etesevimab increases the benefits of covid-19 treatment: Real-world experience from the liguria region 40
Role of raltegravir in patients co-infected with HIV and HCV in the era of direct antiviral agents 34
HCMV-controlling NKG2C+ NK cells originate from novel circulating inflammatory precursors 32
A Web-Based Data Collection Platform for Fragility Evaluation in Senior HIV+ Patients 31
A Web-Based Data Collection Platform for Frailty Evaluation in Senior HIV+ Patients 26
Nine ideas to improve the clinical management of HIV infected patients during the COVID-19 pandemic 24
Hypertensive versus HIV-infected patients: Who has the greatest target organ damage? Comparison of carotid plaque prevalence, intima media thickness and renal resistive index in the two groups of patients 21
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study 20
Ten Years of Medical Informatics and Standards Support for Clinical Research in an Infectious Diseases Network 15
Safety evaluation of current therapies for high-risk severely ill patients with carbapenem-resistant infections 9
Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors 3
People with HIV pioneers of injectable cabotegravir and rilpivirine long acting in Italy: who are they? 3
Residual phenotypic susceptibility to doravirine in multidrug resistant HIV-1 from subjects enrolled in the PRESTIGIO Registry 2
Totale 1.633
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.672
article - articoli 6.025
book - libri 0
conference - conferenze 459
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 188
Totale 13.344
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020372 0 8 5 24 32 47 69 35 43 61 38 10
2020/2021265 8 20 67 38 15 37 1 14 8 26 8 23
2021/2022242 4 9 17 25 11 16 13 51 22 31 11 32
2022/2023364 33 46 1 43 60 42 1 28 44 12 52 2
2023/2024184 4 23 0 24 14 37 12 10 8 8 19 25
2024/202525 23 2 0 0 0 0 0 0 0 0 0 0
Totale 1.633